SouzanSanatiMD
Pathology • West Hollywood, CACytopathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology
Assistant Professor, Pathology & Immunology, Washington University School of Medicine
Dr. Sanati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
# SB290
West Hollywood, CA 90048Phone+1 310-248-6240Fax+1 310-439-1906
Education & Training
Yale-New Haven Medical CenterFellowship, Gynecologic Pathology, 2008 - 2009
Washington University/B-JH/SLCH ConsortiumFellowship, Cytopathology, 2006 - 2007- Washington University/B-JH/SLCH ConsortiumFellowship, Selective Pathology, 2005 - 2006
University of Texas Medical Branch HospitalsResidency, Pathology-Anatomic and Clinical, 2001 - 2005
Iran University of Medical SciencesClass of 1993
Certifications & Licensure
CA State Medical License 2015 - 2025
IL State Medical License 2016 - 2020
MO State Medical License 2007 - 2020- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Clinical Trials
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer Start of enrollment: 2013 Apr 10
- Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer Start of enrollment: 2014 Aug 01
- Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer Start of enrollment: 2014 Apr 02
- Join now to see all
Publications & Presentations
PubMed
- 41 citationsPotential Novel Therapy Targets in Neuroendocrine Carcinomas of the BreastSemir Vranic, Juan P. Palazzo, Souzan Sanati, Elena Florento, Elma Contreras
Clinical Breast Cancer. 2019-04-01 - 8 citationsEarly Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical TomographyQuing Zhu, Foluso O. Ademuyiwa, Catherine A. Young, Catherine M. Appleton, Matthew F. Covington
Breast Cancer Research and Treatment. 2021-05-10 - 107 citationsProteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-lin Huang, Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena
Nature Communications. 2017-03-28
Journal Articles
- Proteogenomic Integration Reveals Therapeutic Targets in Breast Cancer XenograftsSouzan Sanati, Jana W Qiao, Xian Chen, Matthew J Ellis, Cynthia Ma, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
